Sentence examples for reimbursement list from inspiring English sources

In case of overspending, AIFA can apply generalised price reductions or modify the level of national pharmaceutical coverage, by delisting entire classes of drugs from the reimbursement list or by limiting the prescription of reimbursed medicines to specified indications.

In France, some drugs have been on the reimbursement list for years, despite their therapeutic value having long been in doubt, says Philippe Cottet, an analyst with Crédit Lyonnais.

The secret, says Eric Stanchfield, head of health-care purchasing, was a strict reimbursement list based on drugs' clinical effectiveness, a pharmacy benefits manager with transparent accounting and a willingness to be tough in negotiations with drug firms.

"Already no new chemical entities have been added to the reimbursement list in the past six years," laments Mark Loughran, head of the Polish operations of GlaxoSmithKline.What for the generics, now that their countries have brought their patent laws into line with the EU's ideas?

While drugs are typically not included on the public reimbursement list, many cancer drugs are funded publically [2].

Some media also reported that a drug might pass through a chain of more than ten steps, from a pharmaceutical factory to the national drug reimbursement list, creating a profit of hundreds or thousands of its cost.

Drugmakers' investment in R&D may well pay off when they negotiate to get their drugs on to official reimbursement lists.Like India, China has its drawbacks.

With so labor-intensive and time-consuming a source of raw materials underpinning its business, Serono, which moved its headquarters to Geneva in 1977, was already beginning to look outmoded when it got a shock in 1993: Italy struck two of Serono's most important drugs off its reimbursement lists, wiping out $250 million in annual sales almost overnight.

There is also issue of nations training enough pharmaco-economic experts to facilitate CEAP and CEAMD for, for example, both pre and post reimbursement listing.

Prescribing restrictions or removal of products from reimbursement lists to encourage generic prescribing has been used in some European countries but not in the UK.

Expert evaluations of the safety, efficacy and cost-effectiveness of pharmaceutical and medical devices, prior to marketing approval or reimbursement listing, collectively represent a globally important public good.